Studies on some possible mechanisms of potentiation of hexobarbital hypnosis by pilocarpine, muscarine and arecoline.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001115:Arecoline / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001786:Blood Glucose / Q000032:analysis; D001923:Brain Chemistry / Q000187:drug effects; D004357:Drug Synergism; D005663:Furans / Q000494:pharmacology; D006591:Hexobarbital / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D008099:Liver / Q000201:enzymology / Q000378:metabolism; D008297:Male; D051379:Mice; D010277:Parasympathomimetics / Q000494:pharmacology*; D010862:Pilocarpine / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012890:Sleep / Q000187:drug effects*; D013997:Time Factors
D000470:Alkaloids; D001786:Blood Glucose; D005663:Furans; D006993:Hypnotics and Sedatives; D010277:Parasympathomimetics; D000644:Quaternary Ammonium Compounds; D010862:Pilocarpine; D001115:Arecoline; D001285:Atropine; D006591:Hexobarbital